Related Experiment Videos

Dioscin inhibits colon cancer cells' growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and

Shu Li1, Binbin Cheng2, Lixin Hou1

  • 1Department of Gastroenterology, Baoshan Branch, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.

Anti-Cancer Drugs
|February 2, 2018
PubMed

Insights

Dioscin, a plant-derived saponin, effectively inhibits human colon cancer cell growth. It triggers apoptosis via reactive oxygen species (ROS) and the JNK/p38-MAPK pathway, offering a potential natural anticancer agent.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Dioscin is a natural steroid saponin with demonstrated anticancer properties.
  • Colon cancer remains a significant global health challenge requiring novel therapeutic strategies.

Purpose of the Study:

  • To investigate the antitumor effects of dioscin on human colon cancer cells.
  • To elucidate the molecular mechanisms underlying dioscin-induced apoptosis.

Main Methods:

  • Cytotoxicity assessed using MTT assay and BrdU incorporation.
  • Apoptosis induction analyzed via flow cytometry.
  • Western blot and immunofluorescence used to study protein expression and localization.

Main Results:

  • Dioscin significantly inhibited colon cancer cell growth in a dose- and time-dependent manner.
  • Dioscin induced apoptosis through reactive oxygen species (ROS) generation, mitochondrial dysfunction, and caspase activation.
  • Apoptosis was linked to JNK and p38-MAPK pathway activation, which was reversed by ROS scavenging.

Conclusions:

  • Dioscin exhibits potent antitumor activity against human colon cancer cells.
  • The mechanism involves ROS-mediated activation of the JNK/p38-MAPK pathway, leading to apoptosis.
  • Dioscin represents a promising natural compound for colon cancer therapy.

Related Concept Videos